EU and drug maker AstraZeneca settle Covid vaccine supply dispute, ending Brussels’ court action

The European

The European Commission and AstraZeneca have announced that the two parties have settled their long-standing dispute concerning the supply of the drug manufacturer’s Covid-19 vaccine, ending Brussels’ pending court action.

In a statement released by the European Commission on Friday, the bloc confirmed that a resolution had been made. “The EU and AstraZeneca have reached an agreement which will secure the delivery of the remaining COVID-19 vaccine doses to Member States under the terms of the Advance Purchase Agreement concluded on 27 August 2020 with AstraZeneca.”

Continue reading